Page 4 - Precision Diagnostics News Today

/PRNewswire/ -- The "Fertility Test Market: Global Market Size, Forecast, Insights, and Competitive Landscape" report has been added to...

The nanotechnology market in India is expanding quickly, with numerous applications in the healthcare, consumer items, energy, and the military sector.

therascreenKRAS RGQ PCR kit approved as a companion diagnostic to aid in identifying non-small cell lung cancer (NSCLC) patients eligible for treatment with KRAZATI (adagrasib) KRAS mutations

13.12.2022 - QIAGEN (NYSE:QGEN; Frankfurt Prime Standard: QIA) has announced the U.S. Food and Drug Administration (FDA) approval of its therascreen KRAS RGQ PCR kit (therascreen KRAS kit) as a companion diagnostic test to Mirati Therapeutic’s drug KRAZATI ... Seite 1

/PRNewswire/ -- The "Oncology Precision Medicine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 By Ecosystem, By...

Cristo Rey San Diego High School will give low-income students a college preparatory education and work study jobs at San Diego companies.

SAN DIEGO, Oct. 24, 2022 /PRNewswire/ -- Invivoscribe is pleased to announce that they have filed a supplemental Pre-Market Approval (sPMA) submis...

Fred Hutch computational biologist Dr. Gavin Ha received an NIH New Innovator Award to develop new assays and computational methods that will allow him to mine cancer patient blood samples for new information that can improve diagnosis, treatment and disease monitoring.

Initial development and validation of clinical trial assay Next-generation sequencing (NGS) based assay targeting LRRK2 from blood samples Collaboration expands QIAGEN's NGS testing

/PRNewswire/ -- Neuron23™ Inc., an early stage biotechnology company focused on developing precision medicines for genetically defined neurological and...